SCHEMBL4492270

SCHEMBL4492270

CNCc1cccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2cccc(CC(=O)O)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 6/20 0.38
HPSE Q9Y251 2/20 0.37
PPARD Q03181 6/20 0.37
PPARG P37231 5/20 0.37
PPARA Q07869 5/20 0.37
SELP P16109 2/20 0.35
SELE P16581 2/20 0.35
BACE1 P56817 1/20 0.35
ANO1 Q5XXA6 1/20 0.35
TGM2 P21980 1/20 0.34
AGBL2 Q5U5Z8 1/20 0.34
PLK4 O00444 1/20 0.34
CHEK1 O14757 1/20 0.34
AURKA O14965 1/20 0.34
MAPK13 O15264 1/20 0.34
PDPK1 O15530 1/20 0.34
DAPK3 O43293 1/20 0.34
DYRK3 O43781 1/20 0.34
RPS6KA5 O75582 1/20 0.34
PRKD3 O94806 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4492265 1.00 NR1H4 (0.38) NR1H4HPSEPPARDPPARGPPARA
SCHEMBL4501934 0.93 NR1H4 (0.38) NR1H4HPSEPPARDPPARGPPARA
SCHEMBL4501927 0.93 NR1H4 (0.38) NR1H4HPSEPPARDPPARGPPARA
SCHEMBL4494331 0.93 BACE1 (0.39) NR1H4HPSEBACE1TGM2AGBL2
SCHEMBL4494324 0.93 BACE1 (0.39) NR1H4HPSEBACE1TGM2AGBL2
SCHEMBL226889 0.91 FFAR1 (0.40) NR1H4PPARDPPARGPPARABACE1
SCHEMBL226888 0.91 FFAR1 (0.40) NR1H4PPARDPPARGPPARABACE1
SCHEMBL228081 0.90 BACE1 (0.43) NR1H4HPSEPPARDPPARGPPARA
SCHEMBL228080 0.90 BACE1 (0.43) NR1H4HPSEPPARDPPARGPPARA
SCHEMBL4492239 0.90 NR1H4 (0.38) NR1H4HPSEPPARDPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR NR1H4 544/4885HPSE 4355/4885PPARD 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.